Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 27OTHER_GOV 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Capecitabine 28apatinib 26Oxaliplatin 24Cisplatin 24tislelizumab 23Gemcitabine 23Irinotecan 19Paclitaxel 18Carboplatin 18Docetaxel 15Bevacizumab 15Fluorouracil 14Drug Therapy 13Cyclophosphamide 11pembrolizumab 10camrelizumab 10Vinorelbine 9Radiation 9S 1 (combination) 8Leucovorin 8Cetuximab 8toripalimab 7sintilimab 7Rituximab 7Erlotinib Hydrochloride 7pyrotinib 6Gefitinib 6Albumin-Bound Paclitaxel 6fludarabine 5anlotinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Simvastatin × Clear all
NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

National Cancer Center, Korea

Phase 2 Completed
68 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Unknown
192 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00452244 2017-08-25

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 2 Completed
110 enrolled
Thoracic

Lung Neoplasms

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

National Cancer Center, Korea

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡